Braithwaite IE, Cai F, Tom JA, Galanter JM, et al. Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: a randomized, controlled, proof-of-activity trial. J Allergy Clin Immunol 2021 Mar 17. pii: S0091-6749(21)00422.
PMID: 33744327